CervoMed (CRVO) Receivables - Other (2023 - 2025)
CervoMed (CRVO) has disclosed Receivables - Other for 6 consecutive years, with $426993.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 81.06% to $426993.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $426993.0 through Dec 2025, down 81.06% year-over-year, with the annual reading at $426993.0 for FY2025, 81.06% down from the prior year.
- Receivables - Other hit $426993.0 in Q4 2025 for CervoMed, down from $1.4 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.4 million in Q2 2025 to a low of $264148.0 in Q3 2024.
- Historically, Receivables - Other has averaged $1.3 million across 3 years, with a median of $1.4 million in 2025.
- Biggest YoY gain for Receivables - Other was 415.39% in 2025; the steepest drop was 81.06% in 2025.
- Year by year, Receivables - Other stood at $915404.0 in 2023, then soared by 146.26% to $2.3 million in 2024, then tumbled by 81.06% to $426993.0 in 2025.
- Business Quant data shows Receivables - Other for CRVO at $426993.0 in Q4 2025, $1.4 million in Q3 2025, and $2.4 million in Q2 2025.